Literature DB >> 21792881

Functional role of inositol-1,4,5-trisphosphate-3-kinase-A for motility of malignant transformed cells.

Sabine Windhorst1, Tatyana Kalinina, Katharina Schmid, Christine Blechner, Neele Kriebitzsch, Robin Hinsch, Lydia Chang, Lena Herich, Udo Schumacher, Georg W Mayr.   

Abstract

Cell migration is one of the hallmarks of metastatic disease and thus identification of migration promoting proteins is crucial for the understanding of metastasis formation. Here we show that the neuron-specific, F-actin bundling inositol-1,4,5-trisphosphate-3-kinase-A (ITPKA) is ectopically expressed in tumor cells and critically involved in migration. Down-regulation of ITPKA expression in transformed cell-lines with ectopic expression of ITPKA significantly decreased migration and the number of linear and branched cell protrusion. Conversely, up-regulation of ITPKA in tumor cell lines with low endogenous ITPKA expression increased migration and formation of cell processes. In vitro, ITPKA alone induced the formation of linear actin filaments, whereas ITPKA mediated formation of branched protrusions seems to result from interaction between ITPKA and the F-actin cross-linking protein filamin C. Based on these actin-modulating and migration-promoting effects of ITPKA we examined its expression in clinical samples of different tumor entities, starting with the analysis of multiple tumor tissue arrays. As in lung adenocarcinoma specimens, the highest ITPKA expression rate was found, this tumor entity was examined in more detail. ITPKA was expressed early in adenocarcinoma progression (pN0) and was largely maintained in invasive and metastatic tumor cell populations (pN1/2, lymph node metastases). Together with our result that high expression of ITPKA increases motility of tumor cells we conclude that the observed expression of ITPKA early in tumor development increases the metastatic potential of lung adenocarcinoma cells. Therefore, we suggest that ITPKA may be a promising therapeutic molecular target for anti metastatic therapy of lung cancer.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21792881     DOI: 10.1002/ijc.25782

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells.

Authors:  Alessandra Pincini; Giusy Tornillo; Francesca Orso; Marianna Sciortino; Brigitte Bisaro; Maria Del Pilar Camacho Leal; Antonio Lembo; Maria Felice Brizzi; Emilia Turco; Cristiano De Pittà; Paolo Provero; Enzo Medico; Paola Defilippi; Daniela Taverna; Sara Cabodi
Journal:  Cell Cycle       Date:  2013-06-28       Impact factor: 4.534

2.  Design and Synthesis of an Inositol Phosphate Analog Based on Computational Docking Studies.

Authors:  Zhenghong Peng; David Maxwell; Duoli Sun; Yunming Ying; Paul T Schuber; Basvoju A Bhanu Prasad; Juri Gelovani; Wai-Kwan Alfred Yung; William G Bornmann
Journal:  Tetrahedron       Date:  2014-01-28       Impact factor: 2.457

3.  ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers.

Authors:  Yi-Wei Wang; Xiaotu Ma; Yu-An Zhang; Mei-Jung Wang; Yasushi Yatabe; Stephen Lam; Luc Girard; Jeou-Yuan Chen; Adi F Gazdar
Journal:  J Thorac Oncol       Date:  2016-05-24       Impact factor: 15.609

Review 4.  Inositol-1,4,5-trisphosphate 3-kinase-A (ITPKA) is frequently over-expressed and functions as an oncogene in several tumor types.

Authors:  Sabine Windhorst; Kai Song; Adi F Gazdar
Journal:  Biochem Pharmacol       Date:  2017-04-02       Impact factor: 5.858

5.  ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway.

Authors:  Xiang Zhu; An Xu; Yang Zhang; Nan Huo; Rui Cong; Luyuan Ma; Zhong Chu; Zhi Tang; Xiaofeng Kang; Shaozhong Xian; Xiaojie Xu
Journal:  Onco Targets Ther       Date:  2020-10-15       Impact factor: 4.147

6.  Role of km23-1 in RhoA/actin-based cell migration.

Authors:  Qunyan Jin; Nageswara R Pulipati; Weidong Zhou; Cory M Staub; Lance A Liotta; Kathleen M Mulder
Journal:  Biochem Biophys Res Commun       Date:  2012-10-15       Impact factor: 3.575

7.  Relationship of ITPKA expression with the prognosis of breast cancer.

Authors:  Jie Zhang; Sujie Zhang; Xiaoyan Li; Hongying Pi
Journal:  Mol Genet Genomic Med       Date:  2021-02-23       Impact factor: 2.183

8.  TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma.

Authors:  Zhou Guoren; Fan Zhaohui; Zhu Wei; Wang Mei; Wu Yuan; Shi Lin; Xu Xiaoyue; Zhang Xiaomei; Shen Bo
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

9.  ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.

Authors:  Jianbiao Li; Ying-Hui Zhu; Pinzhu Huang; Baozhu Zhang; Jian Sun; Xin-Yuan Guan
Journal:  Diagn Pathol       Date:  2015-08-07       Impact factor: 2.644

10.  Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma.

Authors:  Heike Zabeck; Hendrik Dienemann; Hans Hoffmann; Joachim Pfannschmidt; Arne Warth; Philipp A Schnabel; Thomas Muley; Michael Meister; Holger Sültmann; Holger Fröhlich; Ruprecht Kuner; Felix Lasitschka
Journal:  PLoS One       Date:  2018-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.